Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

New Cancer Targets – NCT Conference

Heidelberg, September 23rd-24th 2013

Hosted by the National Center for Tumor Diseases (NCT) Heidelberg and celebrating the 40th Heidelberg Grand Round, the 2013 Conference on New Cancer Targets  will gather academics, scientists,clinicians and pharmaceutical industry representatives to reflect innovations in therapeutics development, targeted treatments and early detection and prevention strategies.

Characterization of key mutations and molecular pathways target diagnostic and therapeutic intervention. Prediction of treatment response with substantially increased accuracy stratifies particular patient groups and will allow to eventually individualizing both cancer treatment and prevention.
Further clinical progress in cancer care will be achieved through effective translation of basic science into diagnostic, therapeutic and preventive clinical trials and efficient new drug development for maximal patient benefit.

For a joint approach and optimal exchange of information, the NCT Conference will provide the maximum amount of interaction and discussion through an exciting range of talks and workshops.

We hope you will join us at our NCT Conference on 23rd-24th September 2013 in the beautiful city of Heidelberg and strengthen our links in translational cancer research.

Sponsored by:

to top
powered by webEdition CMS